Sera Prognostics, Inc. (SERA)
SERA Stock Price Chart
Explore Sera Prognostics, Inc. interactive price chart. Choose custom timeframes to analyze SERA price movements and trends.
SERA Company Profile
Discover essential business fundamentals and corporate details for Sera Prognostics, Inc. (SERA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
15 Jul 2021
Employees
63.00
Website
https://seraprognostics.comCEO
Zhenya Lindgardt
Description
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
SERA Financial Timeline
Browse a chronological timeline of Sera Prognostics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.14, while revenue estimate is $71.38k.
Earnings released on 6 May 2026
EPS came in at -$0.17 falling short of the estimated -$0.16 by -6.25%, while revenue for the quarter reached $14.00k , missing expectations by -79.00%.
Earnings released on 18 Mar 2026
EPS came in at -$0.16 surpassing the estimated -$0.17 by +5.88%, while revenue for the quarter reached $10.00k , missing expectations by -68.52%.
Earnings released on 13 Nov 2025
EPS came in at -$0.16 surpassing the estimated -$0.19 by +15.79%, while revenue for the quarter reached $16.00k , missing expectations by -68.22%.
Earnings released on 6 Aug 2025
EPS came in at -$0.16 surpassing the estimated -$0.21 by +23.81%, while revenue for the quarter reached $17.00k , missing expectations by -88.67%.
Earnings released on 7 May 2025
EPS came in at -$0.20 surpassing the estimated -$0.24 by +16.67%, while revenue for the quarter reached $38.00k , missing expectations by -24.00%.
Earnings released on 19 Mar 2025
EPS came in at -$0.25 falling short of the estimated -$0.23 by -8.70%, while revenue for the quarter reached $24.00k , beating expectations by +65.52%.
Earnings released on 6 Nov 2024
EPS came in at -$0.24 falling short of the estimated -$0.22 by -9.09%, while revenue for the quarter reached $29.00k , missing expectations by -66.63%.
Earnings released on 7 Aug 2024
EPS came in at -$0.25 falling short of the estimated -$0.23 by -8.70%, while revenue for the quarter reached $24.00k , missing expectations by -70.00%.
Earnings released on 8 May 2024
EPS came in at -$0.25 falling short of the estimated -$0.23 by -8.70%, while revenue for the quarter reached $39.00k , missing expectations by -40.68%.
Earnings released on 20 Mar 2024
EPS came in at -$0.25 matching the estimated -$0.25, while revenue for the quarter reached $41.00k , missing expectations by -56.24%.
Earnings released on 8 Nov 2023
EPS came in at -$0.23 surpassing the estimated -$0.30 by +23.33%, while revenue for the quarter reached $42.00k , missing expectations by -57.66%.
Earnings released on 9 Aug 2023
EPS came in at -$0.34 matching the estimated -$0.34, while revenue for the quarter reached $123.00k , beating expectations by +0.33%.
Earnings released on 10 May 2023
EPS came in at -$0.34 surpassing the estimated -$0.35 by +2.86%, while revenue for the quarter reached $100.00k , meeting expectations.
Earnings released on 22 Mar 2023
EPS came in at -$0.31 surpassing the estimated -$0.42 by +26.19%, while revenue for the quarter reached $65.00k , missing expectations by -51.25%.
Earnings released on 9 Nov 2022
EPS came in at -$0.35 surpassing the estimated -$0.40 by +12.50%, while revenue for the quarter reached $87.00k , missing expectations by -20.91%.
Earnings released on 10 Aug 2022
EPS came in at -$0.37 surpassing the estimated -$0.40 by +7.50%, while revenue for the quarter reached $78.00k , missing expectations by -22.00%.
Earnings released on 10 May 2022
EPS came in at -$0.40 falling short of the estimated -$0.34 by -17.65%, while revenue for the quarter reached $38.00k , missing expectations by -43.00%.
Earnings released on 29 Mar 2022
EPS came in at -$0.41 falling short of the estimated -$0.29 by -41.38%, while revenue for the quarter reached $26.00k , missing expectations by -80.50%.
Earnings released on 9 Nov 2021
EPS came in at -$0.39 falling short of the estimated -$0.22 by -77.27%, while revenue for the quarter reached $23.00k , beating expectations by +18.54%.
Earnings released on 30 Aug 2021
EPS came in at -$3.17 falling short of the estimated -$1.26 by -151.59%, while revenue for the quarter reached $20.00k , missing expectations by -92.88%.
SERA Stock Performance
Access detailed SERA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
